Overview

Pilot Study Evaluating the Efficacy of a Topical PDE4 Inhibitor for Morphea

Status:
Completed
Trial end date:
2020-03-10
Target enrollment:
Participant gender:
Summary
This is a pilot study to determine the safety and clinical efficacy of crisaborole 2% ointment in the treatment of morphea.
Phase:
Phase 2
Details
Lead Sponsor:
Duke University
Collaborator:
Pfizer
Treatments:
Phosphodiesterase 4 Inhibitors